EMA Launches Review of Clot Risk With AstraZeneca COVID Vaccine
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The Pharmacovigilance Risk Assessment Committee (PRAC) […]
A novel therapy that combines a muscarinic receptor agonist with an anticholinergic agent is associated with a greater reduction in […]adverse effects
‘Landmark’ Schizophrenia Drug in the Wings?